Chugai Pharma’s Evrysdi tablets 5mg receives Japanese approval to treat spinal muscular atrophy: Saturday, March 29, 2025, 11:00 Hrs [IST] Chugai Pharmaceutical Co., Ltd. announ ...
Merck’s pembrolizumab with berahyaluronidase alfa demonstrates noninferior PK compared to IV Keytruda in pivotal 3475A-D77 trial: Rahway, New Jersey Saturday, March 29, 2025, 10 ...
Sanofi & Regeneron’s Dupixent receives Japanese marketing approval to treat patients with COPD: Paris Saturday, March 29, 2025, 09:00 Hrs [IST] The Ministry of Health, Labour an ...
AiMED welcomes Centre's move onboarding members to make EPCMD functional: Our Bureau, New Delhi Friday, March 28, 2025, 16:30 ...
Anti-dumping investigation initiated on imports of EDA from China, EU, Saudi Arabia & Taiwan: Shardul Nautiyal, Mumbai Saturday, March 29, 2025, 08:00 Hrs [IST] The Directorate Ge ...
NPPA notifies revised prices of certain products based on WPI increase: Gireesh Babu, New Delhi Saturday, March 29, 2025, 08:00 Hrs [IST] The National Pharmaceutical Pricing Autho ...
NPPA asks Bayer Zydus Pharma to continue selling Urografin for one more year: Gireesh Babu, New Delhi Saturday, March 29, 2025, 08:00 Hrs [IST] The National Pharmaceutical Pricing ...
DI of Bhubaneswar-V Range issues guidelines to stakeholders on counterfeit drugs: Peethaambaran Kunnathoor, Chennai Saturday, March 29, 2025, 08:00 Hrs [IST] Concerned over the po ...
US FDA grants fast track designation to Sanofi’s mRNA vaccine candidate for prevention of chlamydia infection: Paris Friday, March 28, 2025, 12:00 Hrs [IST] The US Food and Drug ...